How to Apply: Innovative Medicines Initiative 2 (IMI 2) Programme Grants

About this program

The Innovative Medicines Initiative 2 (IMI 2) is a public–private partnership that funds collaborative projects to accelerate development of safer, more effective medicines by uniting industry, academia, SMEs, patient organisations, regulators and public laboratories. The application is a five-step process: identify a suitable Call for Proposals, assemble project partners, obtain access to the IMI electronic submission system (SOFIA), register in the IMI Beneficiary Register, and submit the proposal; IMI provides a manual, evaluation form and partner-search resources to support applicants. Eligible applicants are consortia comprising at least three legal entities established in different EU Member States or associated countries; participants may include companies, universities, public labs, SMEs, patient groups and regulators. No funding amounts or submission deadlines are provided in the source; consult the specific Call for Proposals for budget and timing details.